Back

Atherosclerosis as a risk factor in the prognosis of the survival of patients with COPD

13 March 2021 (08:30 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Secondary Prevention ACVC Premium Access ACVC 2021

About the speaker

Photo
Doctor Stanislav Kotlyarov

Ryazan State Medical University, Ryazan (Russian Federation)

153 More presentations in this session

Presentation thumbnail
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Portugal
Doctor I. Lizano-Diez (Barcelona, ES)
Abstract
Presentation thumbnail
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Belgium
Doctor I. Lizano-Diez (Barcelona, ES)
Abstract
Presentation thumbnail
The clinical significance of blood lactate levels in evaluation of adult patients with Veno-Arterial Extracorporeal Membrane Oxygenation .
Assistant Professor M. Laimoud (Riyadh, SA)
Abstract
Presentation thumbnail
Implantable loop recorder: experience of a center
Doctor C. Marques Pires (Braga, PT)
Abstract
Presentation thumbnail
Bleeding predictors in acute coronary syndrome: does the age or clinical presentation matters?
Doctor C. Marques Pires (Braga, PT)
Abstract

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

ACVC 2021

13 March 2021 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Features and risk factors for the development of acute myocardial infarction in patients with chronic obstructive pulmonary disease, depending on the severity
29 June 2021
thumbnail
Congress Presentation
25-year survival of patients with atherosclerotic non-obstructive coronary plaques
1 September 2025
thumbnail
Congress Presentation
Predictors of survival in patients submitted to typical atrial flutter ablation
27 August 2021
thumbnail
Congress Presentation
Pace of arterial aging and its association with cardiovascular risk factors
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources